New study aims to pave the way for treatments of a rare eye disease

NCT ID NCT07228793

Recruiting now Knowledge-focused Sponsor: Sensor Technology for Deafblind Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 45 adults with retinitis pigmentosa caused by EYS gene mutations to understand how the disease progresses over 48 months. Researchers will measure vision changes using eye exams and genetic testing. The goal is to identify reliable ways to track the disease, which will help design better clinical trials for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help design better clinical trials for treatments targeting EYS-related retinitis pigmentosa.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to a therapy, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EYE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eye disorder retinitis pigmentosa retinitis pigmentosa 25

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EYE DISEASES RETINITIS PIGMENTOSA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Oftalmic Clinical Research Center
RECRUITING

Moscow, 125167, Russia

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.